Fiche du document
2015
- doi: 10.1097/CEJ.0000000000000082
- issn: 0959-8278
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1097/CEJ.0000000000000082
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/25494289
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1473-5709
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_885D158D859A9
info:eu-repo/semantics/restrictedAccess , Restricted: indefinite embargo , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Patients--Mortality Mortality, Law of Carcinoma Cancers Malignancy (Cancer) Malignant tumors Mammography BreastsCiter ce document
J.L. Bulliard et al., « Abolishing mammography screening programs? », Serveur académique Lausannois, ID : 10.1097/CEJ.0000000000000082
Métriques
Partage / Export
Résumé
Biller-Andorno and Jüni (2014), in a widely debated commentary published in the May 22 issue of the New England Journal of Medicine, accept the concept that mammography every 2 years from age 50 can decrease breast cancer mortality by 20%, that is, from five to four deaths per 1000 women over a 10-year period. Both the absolute and the relative risk of breast cancer death may vary depending on the baseline mortality rates in various populations and on the impact of screening mammography in reducing breast cancer mortality, which may well vary around the 20% estimate adopted. We accept, therefore, that there are still uncertainties in the absolute and relative impact of mammography screening on breast cancer mortality, given the different study schemes and mammography intervals, the differences in populations, and the continuous improvements in technology (Warner, 2011; Independent UK Panel on Breast Cancer Screening, 2012). We also agree on the observation that mammography has an appreciable impact on breast cancer mortality (Bosetti et al., 2012), but clearly a much smaller one on total mortality.